{
  "id": "mhgap#risk_safety_fe9a341c",
  "content": "contraindicated in individuals with liver disease, Implementation considerations\nwhich may not be evident when the person is y The choice of medicine is affected by a number of\nbrought in convulsing and needs emergency factors, including availability, cost and side-effects.\ntreatment. Also, sodium valproate is contraindicated y There are feasibility and affordability issues;\nin inherited metabolic – including mitochondrial intravenous fosphenytoin is not currently on the\n– disorders, which may manifest in children with WHO model list of essential medicines for children\nseizures and status epilepticus. (EMLc) (132).\ny Phenobarbital may cause sedation and respiratory y Children treated for established status epilepticus\ndepression, and the risk may be increased if it is require monitoring and may require ventilatory\nused after benzodiazepines. support; thus, tertiary/secondary care is necessary.\ny Phenytoin is associated with risks for arrhythmia y Delay in initiation and underdosing has been\nand hypotension, and it is difficult to administer in observed in treatment of status epilepticus. To\nparticular settings. terminate status epilepticus as quickly as possible\ny The recommendation that sodium valproate is not medicines should be given in recommended\nrecommended in women and girls of childbearing dosages. There is a need to increase awareness of",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "medium",
    "topics": [
      "stress",
      "risk_safety",
      "management",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Risk Safety contraindicated in individuals with liver disease, Implementation considerations\nwhich may not be evident when the person is y The choice of medicine is affected by a number of\nbrought in convulsing and needs emergency factors, including availability, cost and side-effects.\ntreatment. Also, sodium valproate is contraindicated y There are feasibility and affordability issues;\nin inherited metabolic – including mitochondrial intravenous fosphenytoin is not currently on the\n– disorders, which may manifest in children with WHO model list of essential medicines for children\nseizures and status epilepticus. (EMLc) (132).\ny Phenobarbital may cause sedation and respiratory y Children treated for established status epilepticus\ndepression, and the risk may be increased if it is require monitoring and may require ventilatory\nused after benzodiazepines. support; thus, tertiary/secondary care is necessary.\ny Phenytoin is associated with risks for arrhythmia y Delay in initiation and underdosing has been\nand hypotension, and it is difficult to administer in observed in treatment of status epilepticus. To\nparticular settings. terminate status epilepticus as quickly as possible\ny The recommendation that sodium valproate is not medicines should be given in recommended\nrecommended in women and girls of childbearing dosages. There is a need to increase awareness of Contraindicated in individuals with liver disease, implementation considerations\nwhich may not be evident when the person is y the choice of medicine is affected by a number of\nbrought in convulsing and needs emergency f..."
}